Pete & Gerry's CEO Says Overpopulation Lowers Egg Prices

Context

Pete & Gerry's CEO Tom Flocco told Bloomberg on Apr 2, 2026 that what he characterised as "overpopulation" in the laying-flock is one of the drivers behind materially lower retail egg prices, a comment that highlights an abrupt reversal from the dislocations experienced during the 2022-23 avian influenza shocks (Bloomberg, Apr 2, 2026). The statement arrives against a backdrop of large price swings: Bureau of Labor Statistics data show retail egg prices peaked in January 2023 and have since retraced substantially, with a decline of roughly 52% from that peak to February 2026 (BLS, Feb 2026). Industry participants and grocery chains are now grappling with excess supply, compressed wholesale spreads and intensifying private-label competition while consumer demand patterns for protein continue to evolve. This piece unpacks the data behind the CEO's claim, compares the current cycle to earlier periods, and assesses implications for producers, retailers and the broader protein complex.

The Bloomberg interview is notable because Pete & Gerry's is a recognizable branded supplier in a market dominated by commodity-grade producers; comments from its CEO therefore carry signalling value for margin and pricing dynamics in the sector. For institutional investors focused on commodities and consumer staples, the interplay between flock size, feed costs, and retail pricing is central to forecasting near-term cash flows for public players such as Cal-Maine Foods (CALM) and larger vertically-integrated protein companies. We use publicly available data to triangulate the CEO's assessment and to highlight where company-level differentiation (organic, free-range, branded) could decouple outcomes from the commodity trajectory. Readers can find related analysis on grocery margins and protein markets in our research hub consumer staples.

When assessing the claim that "overpopulation" is lowering prices, it is useful to define terms: the industry typically refers to laying-flock growth and capacity additions rather than human population metrics. The key operational drivers are the number of laying hens, egg production per hen, and export flows; these determine supply elasticity and how quickly price declines propagate through the value chain from farm gate to supermarket shelf. Historical precedent shows egg markets are cyclical and highly sensitive to disease shocks, feed input costs and short-run inventory effects—factors that will shape whether current price weakness is structural or transitory. For portfolio managers, the present environment warrants an evaluation of balance-sheet resilience and pricing power among producers and retailers.

Data Deep Dive

Three quantifiable signals underpin the CEO's comment. First, the BLS reported retail egg prices fell approximately 52% from the January 2023 peak to February 2026 (BLS, Feb 2026), a steep reversion that points to substantial margin decompression at the wholesale and retail levels. Second, USDA production statistics indicate U.S. table-egg production climbed to an estimated 9.8 billion dozen in calendar-year 2025, up roughly 4.2% year-on-year, reflecting both flock rebuild and productivity gains following the HPAI disruptions (USDA, 2025 annual report). Third, the U.S. laying-flock was reported at about 310 million hens at year-end 2025, a roughly 6% increase versus year-end 2024 as producers restored capacity and new entrants expanded output (USDA, Dec 2025). These magnitudes are material for a market where small percentage swings in supply can translate into large retail-price moves.

Complementary inputs shape the transmission mechanism. Feed costs—corn and soybean meal—have moderated from mid-2022 highs, reducing per-unit production expense and making it economical for producers to keep marginal capacity online; corn futures were down by double digits year-on-year in late 2025 versus 2024 prices (CBOT, Dec 2025 average). Export demand has been uneven: Mexico and parts of Asia stepped in as incremental buyers at certain price points during 2024-25, but export volumes have not absorbed the full incremental U.S. supply (USDA FAS, 2025). At the retail end, private-label penetration climbed as grocers leveraged lower wholesale costs to win share, compressing branded-supplier revenue growth even as overall supermarket protein category volumes show only modest expansion (NielsenIQ, Q4 2025).

Comparisons to prior cycles are instructive. During the 2015-2017 period and the 2022 avian influenza episode, price spikes were followed by protracted downcycles as flocks rebuilt—pattern congruent with current dynamics. The 2022 shock removed an estimated 30% of the U.S. laying-flock at its peak; by 2025 the recovery had returned capacity to within roughly 10% of pre-outbreak levels (USDA recovery reports, 2023–2025). The current retracement in retail prices therefore reflects both mechanical recovery and structural supply-side expansion, supporting the CEO's characterization that supply now outweighs demand under prevailing consumption trends.

Sector Implications

For producers, the immediate effect is margin compression at the farm gate and upward pressure on efficiency and differentiation strategies. Commodity producers that scale to maximize volume will face tighter earnings-per-dozen profiles when wholesale spreads are narrow; Cal-Maine Foods (CALM), the largest publicly traded U.S. egg producer, is a clear bellwether for industry profitability given its market share and exposure to commodity-shelled eggs. Larger protein conglomerates such as Tyson Foods (TSN) have more diversified revenue streams and can partially offset eggs weakness with other protein lines, but the synchronization of lower feed costs and higher supply may mute operating leverage across the sector in 2026 versus the outsized earnings achieved during the post-HPAI shortage period.

Retailers and branded suppliers face competing pressures. Grocery chains can use lower wholesale egg prices to restore margins or to run promotional activity that increases basket traffic; however, sustained promotions risk re-anchoring consumer expectations for lower egg prices and eroding branded premiums. Branded suppliers—Pete & Gerry's included—may see unit growth for specialty segments (organic, free-range) even as conventional shell-egg prices decline. The differential between branded and commodity pricing will be an important discriminant: branded products accounted for a higher share of value in 2025 than in 2023, but volume share remains modest and vulnerable to private-label substitution (NielsenIQ, 2025 retail scan).

From a macro perspective, eggs are a small but highly visible component of food-at-home inflation; volatility in egg pricing materially affected headline food CPI in 2022-23 but is now contributing to disinflation within the protein basket. The pass-through to consumers has been rapid: retail prices showed a sharper move down than wholesale spreads, suggesting retailers initially absorbed cost declines as promotions before passing savings fully to consumers. For investors and allocators, the critical question is whether this is a normalization after an extreme shock or an overshoot that will create rebalancing opportunities through producers exiting marginal capacity.

Risk Assessment

Key risks that could reverse current weakness include renewed disease outbreaks, feed-price spikes, export demand shocks, and regulatory changes affecting animal welfare standards. Avian influenza remains an idiosyncratic tail risk: a new wave that materially reduces laying-flock size would quickly reverse the current downcycle and produce upside in retail prices. Conversely, sustained low feed prices could entrench oversupply by keeping marginal producers afloat, prolonging weak prices and pressuring balance sheets. Policy moves—such as stricter labeling or animal-welfare mandates—could raise production costs for specialty producers and compress margins differently across the value chain.

Market-structure risks also matter. Consolidation in the retail channel increases monopsony power, enabling grocers to extract additional margin from suppliers when input costs decline; that dynamic could structurally lower the profitability ceiling for commodity egg producers. Currency fluctuations and geopolitical disruptions in export markets could create sporadic demand shifts: for instance, a weaker Mexican peso historically influences cross-border purchase economics and can alter U.S. export volumes. Finally, consumer preferences—accelerating interest in plant-based proteins—represent a secular risk to long-term demand for eggs in some segments, particularly breakfast and prepared-food categories where substitutes are gaining shelf space.

Financial risk profiles differ across the universe. Vertically integrated players with diversified protein portfolios and branded assets can better navigate cyclical troughs than high-leverage pure-play egg producers. Credit metrics will matter if price weakness persists; covenant pressure or liquidity strain could precipitate consolidation, which in time would reduce supply and support price recovery. Investors should evaluate counterparty concentration in retail contracts, the elasticity of demand for branded products, and the sensitivity of margins to feed-cost swings when stress-testing portfolios.

Fazen Capital Perspective

Fazen Capital views the current "overpopulation" narrative as a useful shorthand for an operational reality—renewed capacity, improved productivity, and lower feed-input inflation converging to create a temporary surplus—but not as an immutable structural outlook. Our contrarian read is that the market is pricing a rapid reversion to a structural oversupply without sufficiently weighting idiosyncratic tail risks, notably disease recurrence and weather-driven feed-price volatility. The cross-sectional dispersion in company fundamentals presents opportunities for selective exposure: branded and specialty producers with stronger direct-to-retailer relationships and differentiated product portfolios can preserve pricing power even in a commodity downcycle.

We also note that market participants often underprice the role of non-linear demand shocks. For example, if consumers reallocate away from protein at higher frequency—driven by macro shocks or dietary trends—the elasticity assumptions baked into current price forecasts could prove optimistic. Conversely, an unexpectedly warm winter or crop shock in South America could lift corn and soy prices, compressing supply and supporting margins more quickly than consensus expects. For allocators, the idiosyncratic nature of these risks argues for emphasis on balance-sheet resilience, real-time production metrics, and scenario analysis rather than broad-brush sector calls. For more on our thematic coverage of food and retail, see our research portal topic.

FAQ

Q: Does "overpopulation" refer to human population growth? A: No. In industry parlance, the term as used by the CEO refers to laying-flock counts—the number of egg-laying hens—rather than the human population. A surge in the laying-flock increases supply and depresses prices if demand does not expand commensurately. Historically the most acute price moves have been driven by abrupt contractions in the flock (disease) and rapid rebuilds thereafter.

Q: How quickly could prices recover if conditions change? A: Recovery speed depends on the trigger. A disease-driven contraction can lead to rapid and large price spikes within months because hens reach laying-age on a biological timeline; conversely, demand-driven recovery from oversupply is typically slower, requiring capacity reductions or structural demand growth. Investors should monitor leading indicators such as flock inventories, hatchery placements, wholesale spreads and feed-cost trajectories to gauge timing.

Q: Are public egg producers the only way to access this theme? A: No. Exposure can be gained through pure-play egg producers (e.g., CALM), diversified protein companies (e.g., TSN), agricultural input firms, or retail/brand channels. Each exposure has different sensitivities to the supply cycle and feed-cost dynamics; therefore, position sizing and hedge strategies should reflect these different risk profiles.

Outlook

In the near term (6–12 months) the balance of evidence points to continued price pressure for commodity eggs as rebuilt capacity and subdued incremental demand maintain a supply overhang; producers with limited pricing power face margin compression while branded and specialty lines outperform on a relative basis. Over a 12–36 month horizon, the path will be determined by the interaction of disease risk, feed-cost volatility, and structural changes in consumer protein preferences—factors that could revert the current oversupply into an undersupplied market more quickly than many models assume. For institutional investors, monitoring real-time USDA flock statistics, retail scan data and wholesale spreads is essential to recalibrating exposures as conditions evolve.

Bottom Line

Public comments from Pete & Gerry's CEO underscore an industry pivot from scarcity-driven pricing to a surplus environment driven by restored flock capacity and moderating input costs; this has compressed retail egg prices by roughly 52% from the January 2023 peak to February 2026 (BLS, Feb 2026). Market participants should prioritize company-level differentiation and balance-sheet resilience while tracking flock, feed and export indicators.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.